Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2016

Feb 24, 2016

30339_dirs_2016-02-24_49bd7402-5e74-4400-a022-f131e4f8b634.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-08-05

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-08-05 Common Stock S 4000.0000 $60.5100 Disposed 14935.0200 Direct

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.